Literature DB >> 2840319

The chemotactic peptide N-formyl methionyl-leucyl-phenylalanine increases mucosal permeability in the distal ileum of the rat.

C von Ritter1, E Sekizuka, M B Grisham, D N Granger.   

Abstract

Activation of granulocytes within the lamina propria by luminally derived bacterial products may represent an important mechanism in the pathogenesis of inflammatory bowel disease. The objective of this study was to determine the effects of luminal perfusion with N-formyl methionyl-leucyl-phenylalanine (FMLP), a bacterial product that attracts and activates granulocytes, on mucosal permeability in different regions of the rat small intestine and colon. Mucosal permeability was measured using blood-to-lumen clearance of 51Cr-ethylenediamine-tetraacetate during luminal perfusion with FMLP (10(-3) to 10(-8) M) dissolved in Tyrode's solution. Of the bowel segments studied, mucosal permeability was significantly increased by FMLP only in the distal 10 cm of ileum. The minimal FMLP concentration required to increase mucosal permeability was 10(-6) M. The increased mucosal permeability induced by FMLP could be prevented by depletion of circulating granulocytes with antineutrophil serum. The greater sensitivity of the distal ileum to FMLP did not correlate with a higher tissue myeloperoxidase activity, but it was associated with a higher basal ethylenediaminetetraacetate clearance. These observations indicate that a high basal mucosal permeability to solutes the size of FMLP (5-6 A radius), rather than a greater number of resident granulocytes in the lamina propria, predisposes the terminal ileum to the inflammatory actions of FMLP.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2840319     DOI: 10.1016/s0016-5085(88)80011-8

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  20 in total

1.  Macromolecular transport across the rabbit proximal and distal colon.

Authors:  J A Hardin; M H Kimm; M Wirasinghe; D G Gall
Journal:  Gut       Date:  1999-02       Impact factor: 23.059

Review 2.  Opioids and the immune system - friend or foe.

Authors:  Lisanne Mirja Plein; Heike L Rittner
Journal:  Br J Pharmacol       Date:  2017-03-23       Impact factor: 8.739

3.  Azathioprine reduces extravasation and neutrophil trafficking in immune complex-mediated inflammation in the rat colon.

Authors:  S N Murthy; T Anania; H R Clearfield
Journal:  Agents Actions       Date:  1991-09

4.  Mucosal subepithelial binding sites for the bacterial chemotactic peptide, formyl-methionyl-leucyl-phenylalanine (FMLP).

Authors:  P Anton; J O'Connell; D O'Connell; L Whitaker; G C O'Sullivan; J K Collins; F Shanahan
Journal:  Gut       Date:  1998-03       Impact factor: 23.059

5.  Increased oxidative stress and decreased antioxidant defenses in mucosa of inflammatory bowel disease.

Authors:  L Lih-Brody; S R Powell; K P Collier; G M Reddy; R Cerchia; E Kahn; G S Weissman; S Katz; R A Floyd; M J McKinley; S E Fisher; G E Mullin
Journal:  Dig Dis Sci       Date:  1996-10       Impact factor: 3.199

6.  Oxidant defense mechanisms in the human colon.

Authors:  M B Grisham; R P MacDermott; E A Deitch
Journal:  Inflammation       Date:  1990-12       Impact factor: 4.092

7.  Increased absorption of polyethylene glycol 600 deposited in the colon in active ulcerative colitis.

Authors:  S Almer; L Franzén; G Olaison; K Smedh; M Ström
Journal:  Gut       Date:  1993-04       Impact factor: 23.059

8.  Neutrophil-independence of the initiation of colonic injury. Comparison of results from three models of experimental colitis in the rat.

Authors:  M G Buell; M C Berin
Journal:  Dig Dis Sci       Date:  1994-12       Impact factor: 3.199

9.  Studies of gut mucosal protein synthesis in a non-steroidal anti-inflammatory drug (NSAID) model of inflammatory bowel disease.

Authors:  A K Banerjee; J S Marway; V R Preedy; T J Peters
Journal:  Gut       Date:  1992-02       Impact factor: 23.059

10.  Role of neutrophils in acetic acid-induced colitis in rats.

Authors:  T Yamada; B J Zimmerman; R D Specian; M B Grisham
Journal:  Inflammation       Date:  1991-10       Impact factor: 4.092

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.